196
Participants
Start Date
October 31, 2010
Primary Completion Date
August 31, 2011
Study Completion Date
October 31, 2011
BGP-15 100 mg QD
Two 50 mg BGP-15 capsules by mouth in the morning; and two Placebo capsules by mouth in the evening
BGP-15 100 mg BID
One 100 mg BGP-15 capsule by mouth in the morning; and one 100 mg BGP-15 capsule by mouth in the evening
Placebo BID
Two Placebo capsules by mouth in the morning; and two Placebo capsules by mouth in the evening
BGP-15 200 mg QD
Two 100 mg BGP-15 capsule by mouth in the morning; and two Placebo capsule by mouth in the evening
BGP-15 200 mg BID
Two 100 mg BGP-15 capsules by mouth in the morning; and two 100 mg BGP-15 capsules by mouth in the evening
BGP-15 400 mg QD
Two 200 mg BGP-15 capsules by mouth in the morning; and two Placebo capsules by mouth in the evening
Semmelweis University 2nd Clinic for Internal Medicine, Budapest
Dr. Bugyi Istvan Hospital, Diabetology Outpatient Clinic, Szentes
DRUG Research Center Hungary Kft., Balatonfüred
Zala County Hospital Department of Diabetology, Zalaegerszeg
Petz Aladar Country Teaching Hospital, Dept of Diabetology and Metabolism, Győr
Medstar Health Research Institute, Hyattsville
Piedmont Medical Research, LLC., Winston-Salem
New Hanover Medical Research, Wilmington
Upstate Pharmaceutical Research, Greenville
Mountain View Clinical Research, Greer
Southeastern Research Associates, Inc., Taylors
Atlanta Pharmaceutical Research, Decatur
Clinical Research of South Florida, Coral Gables
Metabolic Research Institute, Inc., West Palm Beach
Athens Medical Group, Athens
Universitätsklinikum Köln, Cologne
Schwerpunktpraxis Diabetes, Neuwied
Diabetologische Schwerpunktpraxis, Siegen
ICCT Research International, Inc., Chicago
The Center for Pharmaceutical Research, P.C., Kansas City
Juno Research, LLC., Houston
Juno Research, LLC., Katy
Cetero Research-San Antonio, San Antonio
Creekside Endocrine Associates PC, Denver
Nevada Alliance Against Diabetes, Las Vegas
Andrew J. Lewin Medical Corporation DBA National Research Institute, Los Angeles
Center for Clinical Trials, LLC., Paramount
Orange County Research Center, Tustin
Praxis Dr. Schätzl, Großheirath-Rossach
Diabetespraxis Bad Mergentheim, Bad Mergentheim
Lead Sponsor
Collaborators (2)
Integrium
INDUSTRY
Msource Medical Development GmbH
UNKNOWN
Kinexum LLC
UNKNOWN
Thermo Fisher Scientific, Inc
INDUSTRY
Haupt Pharma Wülfing GmbH
UNKNOWN
Barc NV
INDUSTRY
N-Gene Research Laboratories, Inc.
INDUSTRY